Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

Investment Counsel’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$849K	Sell	5,464 -1,020	-16%	-$158K	0.6%	40
2020 Q4	$970K	Hold	6,484	–	–	0.67%	36
2020 Q3	$857K	Hold	6,484	–	–	0.63%	36
2020 Q2	$751K	Hold	6,484	–	–	0.56%	41
2020 Q1	$636K	Hold	6,484	–	–	0.55%	40
2019 Q4	$942K	Hold	6,484	–	–	0.67%	39
2019 Q3	$864K	Hold	6,484	–	–	0.63%	40
2019 Q2	$769K	Sell	6,484 -2,060	-24%	-$241K	0.56%	40
2019 Q1	$1.06M	Hold	8,544	–	–	0.81%	40
2018 Q4	$860K	Hold	8,544	–	–	0.72%	40
2018 Q3	$956K	Hold	8,544	–	–	0.78%	40
2018 Q2	$924K	Hold	8,544	–	–	0.74%	40
2018 Q1	$904K	Sell	8,544 -82	-1%	-$9.52K	0.74%	42
2017 Q4	$1.01M	Hold	8,626	–	–	0.8%	41
2017 Q3	$981K	Hold	8,626	–	–	0.81%	42
2017 Q2	$1.07M	Sell	8,626 -110	-1%	-$13K	0.9%	42
2017 Q1	$1.04M	Hold	8,736	–	–	0.86%	41
2016 Q4	$875K	Hold	8,736	–	–	0.76%	42
2016 Q3	$1.1M	Sell	8,736 -2,637	-23%	-$326K	0.97%	38
2016 Q2	$1.33M	Buy	11,373 +973	+9%	+$110K	1.08%	36
2016 Q1	$1.08M	Buy	10,400 +361	+4%	+$34.9K	1.01%	39
2015 Q4	$1M	Buy	+10,039	New	+$982K	0.89%	40

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Investment Counsel's ZBH Position: Q1 2021 in Review

Investment Counsel reduced its Zimmer Biomet (ZBH) stake by 16% in Q1 2021, selling an estimated $158K and leaving 5,464 shares worth $849K. The position accounts for 0.6% of the portfolio, ranked #40.

Investment Counsel first reported a position in ZBH in Q4 2015 and has held it in 22 quarters since. The position peaked at $1.33M in Q2 2016. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

Investment Counsel held 5,464 shares of Zimmer Biomet worth $849K as of Q1 2021.
Investment Counsel sold 1,020 Zimmer Biomet shares in Q1 2021, an estimated $158K.
Zimmer Biomet made up 0.6% of Investment Counsel's portfolio in Q1 2021, its #40 holding.
Investment Counsel first reported a position in Zimmer Biomet in Q4 2015 and has held it in 22 quarters since.
Investment Counsel's Zimmer Biomet position peaked at $1.33M in Q2 2016.
1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Investment Counsel's 13F filing for Q1 2021, filed 12 Apr 2021.